Belgium - Other Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPrice for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium - 2023
Contents:
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium (FOB) - 2022
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium (CIF) - 2022
- Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium
- Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium
Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium (FOB) - 2022
The average export price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses stood at $22,997 per ton in 2022, with a decrease of -55.6% against the previous year. In general, the export price faced a abrupt setback. The most prominent rate of growth was recorded in 2016 an increase of 36%. The export price peaked at $90,266 per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Italy ($104,481 per ton), while the average price for exports to Hungary ($3,085 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Germany (+7.5%), while the prices for the other major destinations experienced more modest paces of growth.
Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium (CIF) - 2022
In 2022, the average import price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $36,501 per ton, which is down by -37.4% against the previous year. In general, the import price continues to indicate a abrupt contraction. The growth pace was the most rapid in 2013 when the average import price increased by 220%. As a result, import price attained the peak level of $312,648 per ton. From 2014 to 2022, the average import prices failed to regain momentum.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Ireland ($573,185 per ton), while the price for Italy ($12,120 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Canada (+33.3%), while the prices for the other major suppliers experienced more modest paces of growth.
Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium
In 2022, the amount of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses exported from Belgium soared to 7.1K tons, picking up by 75% against 2021. In general, exports showed a significant increase. As a result, the exports reached the peak and are likely to continue growth in the immediate term.
In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses fell rapidly to $163M in 2022. Over the period under review, exports, however, continue to indicate a perceptible decline. The pace of growth appeared the most rapid in 2020 with an increase of 37%. As a result, the exports reached the peak of $254M. From 2021 to 2022, the growth of the exports of remained at a somewhat lower figure.
Export of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium (Million USD) | |||||
---|---|---|---|---|---|
COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
Italy | 26.4 | 50.9 | 40.1 | 40.5 | 15.3% |
France | 2.8 | 7.8 | 12.9 | 39.5 | 141.6% |
Ireland | 119 | 122 | 82.5 | 14.7 | -50.2% |
Netherlands | 1.7 | 4.4 | 5.0 | 7.3 | 62.5% |
Germany | 1.4 | 5.1 | 4.6 | 5.2 | 54.9% |
Spain | 0.1 | 4.0 | 3.5 | 4.8 | 263.4% |
Hungary | N/A | N/A | N/A | 3.8 | 0% |
Portugal | 0.1 | 0.8 | 0.6 | 0.9 | 108.0% |
Others | 33.7 | 58.6 | 60.7 | 46.8 | 11.6% |
Total | 185 | 254 | 210 | 163 | -4.1% |
Top Export Markets for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses from Belgium in 2022:
- France (1891.4 tons)
- Hungary (1219.9 tons)
- Netherlands (962.2 tons)
- Spain (786.0 tons)
- Germany (557.1 tons)
- Italy (387.7 tons)
- Ireland (332.7 tons)
- Portugal (200.4 tons)
Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium
Imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses into Belgium soared to 3.7K tons in 2022, picking up by 160% on 2021. In general, imports continue to indicate a significant expansion. The growth pace was the most rapid in 2020 when imports increased by 279% against the previous year. Imports peaked in 2022 and are expected to retain growth in the near future.
In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses surged to $135M in 2022. Over the period under review, imports showed a significant expansion. The pace of growth was the most pronounced in 2020 with an increase of 254%. Over the period under review, imports of reached the peak figure in 2022 and are likely to see gradual growth in the immediate term.
Import of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Belgium (Million USD) | |||||
---|---|---|---|---|---|
COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
United States | 2.2 | 15.8 | 19.8 | 52.2 | 187.4% |
Netherlands | 14.2 | 21.3 | 21.6 | 44.7 | 46.6% |
Germany | 2.1 | 7.8 | 5.9 | 11.8 | 77.8% |
Italy | 1.1 | 1.4 | 1.4 | 3.1 | 41.3% |
Sweden | 1.4 | 2.1 | 2.4 | 1.2 | -5.0% |
Canada | 1.2 | 26.5 | 0.3 | 0.9 | -9.1% |
United Kingdom | 1.4 | 9.5 | 1.1 | 0.2 | -47.7% |
Others | 6.6 | 22.0 | 30.1 | 20.3 | 45.4% |
Total | 30.1 | 106 | 82.7 | 135 | 64.9% |
Top Suppliers of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses to Belgium in 2022:
- United States (2000.0 tons)
- Netherlands (1257.6 tons)
- Italy (258.4 tons)
- Germany (46.9 tons)
- Sweden (23.0 tons)
- Canada (5.8 tons)
- United Kingdom (1.6 tons)
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Belgium. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
Country coverage:
- Belgium
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Belgium
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Belgium.
This report provides an in-depth analysis of the medicaments containing hormones market in Belgium.
This report provides an in-depth analysis of the medicaments containing insulin market in Belgium.
This report provides an in-depth analysis of the medicaments containing penicillin market in Belgium.
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in Belgium.
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in Belgium.
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
This report provides an in-depth analysis of the global medicaments containing hormones market.
This report provides an in-depth analysis of the global medicaments containing insulin market.
This report provides an in-depth analysis of the global medicaments containing penicillin market.
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.